News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
687,767 Results
Type
Article (40157)
Company Profile (276)
Press Release (647334)
Section
Business (205898)
Career Advice (1987)
Deals (35673)
Drug Delivery (80)
Drug Development (81981)
Employer Resources (167)
FDA (16192)
Job Trends (14940)
News (347857)
Policy (32698)
Tag
Academia (2577)
Africa (722)
Alliances (49799)
Alzheimer's disease (1158)
Approvals (16126)
Arizona (174)
Artificial intelligence (78)
Asia (37580)
Australia (6120)
Bankruptcy (351)
Best Places to Work (11465)
Biosimilars (66)
Biotechnology (200)
Breast cancer (64)
C2C Services and Suppliers (79518)
California (2025)
Canada (978)
Cancer (588)
Career advice (1657)
Cell therapy (141)
China (162)
Clinical research (64382)
Collaboration (175)
Colorado (84)
Compensation (89)
Connecticut (81)
COVID-19 (2505)
Cystic fibrosis (78)
Data (425)
Diabetes (90)
Diagnostics (6067)
Drug pricing (70)
Earnings (84218)
Employer resources (142)
Europe (81374)
Events (109856)
Executive appointments (168)
FDA (16470)
Florida (289)
Funding (174)
Gene therapy (99)
GLP-1 (527)
Government (4333)
Healthcare (18899)
Hotbed/Location (484636)
Illinois (269)
Indiana (151)
Infectious disease (2540)
Inflammatory bowel disease (95)
Interviews (306)
IPO (16333)
Job creations (3645)
Job search strategy (1421)
Kansas (95)
Layoffs (409)
Legal (7868)
Lung cancer (130)
Manufacturing (99)
Maryland (425)
Massachusetts (1652)
Medical device (13117)
Medtech (13122)
Mergers & acquisitions (19228)
Metabolic disorders (270)
Michigan (125)
Minnesota (221)
Neuroscience (1330)
New Jersey (617)
New York (629)
NextGen Class of 2024 (6563)
Non-profit (4513)
North Carolina (605)
Northern California (879)
Obesity (165)
Ohio (111)
Opinion (178)
Patents (77)
Pennsylvania (605)
People (56651)
Pharmaceutical (65)
Phase I (20005)
Phase II (28334)
Phase III (21209)
Pipeline (125)
Postmarket research (2580)
Preclinical (8457)
Radiopharmaceuticals (240)
Rare diseases (148)
Real estate (5945)
Regulatory (21492)
Research institute (2358)
Resumes & cover letters (347)
South America (1099)
Southern California (818)
Startups (3626)
Texas (259)
United States (9079)
Vaccines (496)
Washington State (258)
Weight loss (138)
Date
Today (130)
Last 7 days (566)
Last 30 days (2561)
Last 365 days (37345)
2024 (27189)
2023 (40510)
2022 (51707)
2021 (56242)
2020 (54579)
2019 (47136)
2018 (35514)
2017 (32664)
2016 (32069)
2015 (38087)
2014 (31759)
2013 (26733)
2012 (28937)
2011 (29671)
2010 (27628)
687,767 Results for "champions oncology inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Champions Oncology and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development
Champions Oncology, Inc., a leader in the development of advanced preclinical oncology solutions, has announced a strategic partnership with Medicines Discovery Catapult, enhancing their combined capabilities in the expanding field of radiopharmaceutical therapeutics.
June 4, 2024
·
3 min read
Business
Champions Oncology Reports Quarterly Revenue of $12.0 Million
Champions Oncology, Inc., a global preclinical and clinical research services provider that offers end-to-end oncology solutions, announced its financial results for its third quarter of fiscal 2024, ended January 31, 2024.
March 12, 2024
·
12 min read
Policy
Champions Oncology’s US Laboratory has Acquired Distinguished CAP Accreditation
Champions Oncology, Inc., a global preclinical and clinical research services provider that offers end-to-end oncology solutions, announced that the College of American Pathologists has awarded accreditation to its US-based laboratory.
March 7, 2024
·
2 min read
Press Releases
Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024
September 10, 2024
·
1 min read
Business
Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024
Champions Oncology, Inc. (CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report its financial and operational results for the third quarter ended January 31, 2024, on Tuesday, March 12, 2024, after market close.
March 6, 2024
·
1 min read
Press Releases
Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million
September 12, 2024
·
9 min read
Press Releases
Champions Oncology Reports Quarterly Revenue of $14.0 Million
July 19, 2024
·
13 min read
Business
Champions Oncology Reports Quarterly Revenue of $11.6 Million
Champions Oncology, Inc., a global preclinical and clinical research services provider that offers end-to-end oncology solutions, announced its financial results for its second quarter of fiscal 2024, ended October 31, 2023.
December 12, 2023
·
13 min read
Business
Champions Oncology Announces the Addition of Brady Davis as President
Champions Oncology, Inc., a global preclinical and clinical research services provider that offers end-to-end oncology solutions, has appointed Brady Davis as President to continue to develop new strategic initiatives to drive accelerated growth.
October 17, 2023
·
2 min read
Business
Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 12, 2023
Champions Oncology, Inc., a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report its financial and operational results for the second quarter ended October 31, 2023, on Tuesday, December 12, 2023, after market close.
December 4, 2023
·
1 min read
1 of 68,777
Next
